Showing 1771-1780 of 7447 results for "".
A Promising Pipeline
https://practicaldermatology.com/conferences/maui-derm-2022/a-promising-pipeline/20051/Joel L. Cohen, MD says he's excited about a number of devices he's currently investigating for a wide-variety of medical and aesthetic dermatologic treatments. From body contouring to acne to hair removal, Dr. Cohen shares insights on advancing technologies for several indications.Multidimensional Impact of Prurigo Nodularis
https://practicaldermatology.com/topics/atopic-dermatitis/multidimensional-impact-of-prurigo-nodularis/20048/Like most dermatologists, you may find it challenging to keep up with the rapid discoveries regarding inflammatory skin diseases and new developments in treatment. This informational webinar will provide updates on evolving areas of practice.What's your top travel destination dream?
https://practicaldermatology.com/topics/practice-management/whats-your-top-travel-destination-dream/20038/Misha Rosenbach, MD reflects on how the COVID-19 pandemic and concerns about climate change altered his perspective on travel destination dreams, as well as where he hopes to get back to one day.Five strategies to make the most of prejuvenation-minded dermatology
https://practicaldermatology.com/topics/practice-management/five-strategies-to-make-the-most-of-prejuvenation-minded-dermatology/20042/Congratulations! You, as a practice, were experts in “prejuvenation” well before it was a buzzy term. It is one thing to have a menu of "prevention" and "rejuvenation" oriented services and expertise. It is quite another way to market those services and skills to satisfy the next-generation patient’Optimizing Injectable Results
https://practicaldermatology.com/conferences/asds-2021/optimizing-injectable-results/20021/When it comes to injectables and facial rejuvenation, a panfacial approach can lead to optimal results. But not all patients have the budget for that. Sabrina Fabi, MD shares tips for optimizing results with a low-volume/high-yield treatment plan.Connecting with Industry
https://practicaldermatology.com/series/dermatology-education-foundation/connecting-with-industry/19990/Beyond offering attendees a chance to network with one another, Dermatology Education Foundations meetings are a chance for attendees and industry to interact. Wendy Cantrell, CRNP, DNP says it's great to learn from these knowledgeable representatives, plus an excellent time to tell them how they caScientifically Speaking: Diagnosing and Treating Hair Loss, Part 2
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-diagnosing-and-treating-hair-loss-part-2/19958/From PRP to surgical updates and long-standing interventions, there are many options to address hair loss. It's essential to know the risks and benefits of treatments, including combinations. Host Joel L. Cohen, MD discusses options for hair loss with Marc Avram, MD, Cheryl Burgess, MD, and Reena JoDermWireTV: Who's Injecting? Game on for Top Derm; Rhode Island is Sunucated
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-whos-injecting-game-on-for-top-derm-rhode-island-is-sunucated/19960/New data reveal who is providing cosmetic injections in dermatology and plastic surgery practices. Level Ex enters the dermatology specialty with Top Derm. More than half of all states are now Sunucated. And CSF is coming to Nashville.Removing Obstacles to Dermatologic Care for LGBTQ/GSM Patients
https://practicaldermatology.com/topics/practice-management/removing-obstacles-to-dermatologic-care-for-lgbtqgsm-patients/19935/Members of gender and sexual minority groups may feel less comfortable seeking healthcare than their non-LGBTQ/GSM counterparts. Klint Peebles, MD addresses some of the barriers to access and offers strategies for building more inclusive and welcoming dermatology practices.Psoriasis Update: Understanding the Latest Psoriasis Guidelines
https://practicaldermatology.com/topics/psoriasis/psoriasis-update-understanding-the-latest-psoriasis-guidelines/19777/In a major reversal, the latest psoriasis guidelines recommend against yearly tuberculosis testing for psoriasis patients on biologics who are at low or no risk for TB, says Jashin J. Wu, MD. He also sheds light on studies comparing the 11 biologics that are currently approved for the treatment of p